Researchers are hoping to better understand respiratory viruses like colds and flus through the launch of a new study. The Wellcome Sanger Institute’s new respiratory virus and microbiome initiative (RVI) will lay the groundwork for large-scale surveillance of the viruses.
It will build on the Institute’s genomics expertise and the experience gained while sequencing millions of Covid-19 genomes during the pandemic. The initiative aims to develop the capability for routine genomic surveillance of respiratory viruses, including influenza virus, respiratory syncytial virus (RSV), adenovirus and rhinovirus.
It could also allow emerging pathogens, which could lead to potential pandemics, to be monitored. Experts suggest the data gathered through nose and throat swab samples will lead to a better understanding of common diseases present in the UK.
